Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Stroke & Cerebrovascular Diseases

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jstrokecerebrovasdis.2008.11.009PMID 19560680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Treatments in Acute Stroke

  2006cited by this paper
• 1,026 Experimental treatments in acute stroke

  2006cited by this paper
• Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke

  2005cited by this paper
• A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

  2005cited by this paper
• Peripheral administration of interleukin-1 receptor antagonist (IL-1ra) reduces ischaemic brain damage in the rat

  2005cited by this paper
• Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse

  2004cited by this paper
• Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias

  2004cited by this paper
• The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat.

  2004cited by this paper
• Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model

  2003cited by this paper
• Delayed administration of interleukin‐1 receptor antagonist protects against transient cerebral ischaemia in the rat

  2003cited by this paper
• Role of P2X7 Receptors in Ischemic and Excitotoxic Brain Injury In Vivo

  2003cited by this paper
• Interleukin-1 Influences Ischemic Brain Damage in the Mouse Independently of the Interleukin-1 Type I Receptor

  2002cited by this paper
• Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• Role of IL-1α and IL-1β in Ischemic Brain Damage

  2001cited by this paper
• [Attenuation of reperfusion injury in the mouse transfected interleukin-1 receptor antagonist].

  2000cited by this paper
• Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist.

  1999cited by this paper
• Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

  1999cited by this paper
• Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.

  1998cited by this paper
• Cortical Protection by Localized Striatal Injection of IL-1ra Following Cerebral Ischemia in the Rat

  1997cited by this paper
• Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Neuroprotective Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Focal Cerebral Ischaemia in the Rat

  1996cited by this paper
• Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.

  1996cited by this paper
• Cytokines and the nervous system. I: Expression and recognition.

  1995cited by this paper
• Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.

  1995cited by this paper
• Attenuation of Stroke Size in Rats Using an Adenoviral Vector to Induce Overexpression of Interleukin-1 Receptor Antagonist in Brain

  1995cited by this paper
• Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.

  1992cited by this paper

• Unravelling the neuroinflammatory links in depression: the potential of a lipopolysaccharide preclinical model

  2024cites this paper
• Expanding Role of Interleukin-1 Family Cytokines in Acute Ischemic Stroke

  2024cites this paper
• The efficacy and safety of interleukin-1 receptor antagonist in stroke patients: A systematic review.

  2024cites this paper
• The role of circulating cell-free DNA as an inflammatory mediator after stroke

  2023cites this paper
• Neurovascular Inflammation and Complications of Thrombolysis Therapy in Stroke

  2023cites this paper
• ADAR1 exacerbates ischemic brain injury via astrocyte-mediated neuron apoptosis

  2023cites this paper
• IL-1 Beta—A Biomarker for Ischemic Stroke Prognosis and Atherosclerotic Lesions of the Internal Carotid Artery

  2023cites this paper
• Transmission of NLRP3-IL-1β Signals in Cerebral Ischemia and Reperfusion Injury: from Microglia to Adjacent Neuron and Endothelial Cells via IL-1β/IL-1R1/TRAF6

  2023cites this paper
• Systematic reviews of animal studies – Report of an international symposium

  2023cites this paper
• Systemic Inflammation after Aneurysmal Subarachnoid Hemorrhage

  2023cites this paper
• Impact of Age on Systemic Inflammatory Profile of Patients With ST-Segment–Elevation Myocardial Infarction and Acute Ischemic Stroke

  2022cites this paper
• Cerebroprotective properties of recombinant interleukin-1 receptor - an experimental study.

  2022cites this paper
• Protective Effects of Interleukin-1 Blockade on Group B Streptococcus-Induced Chorioamnionitis and Subsequent Neurobehavioral Impairments of the Offspring

  2022cites this paper
• The immunology of the post-cardiac arrest syndrome.

  2022cites this paper
• Systematic review in evidence-based risk assessment.

  2021cites this paper
• Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis [version 1; peer review: 2 approved]

  2021cites this paper
• Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra

  2021cites this paper
• Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury

  2020cites this paper
• Interrelation of the dynamics of serum concentrations of interleukin-1β, interleukin-6 and interleukin-10 with clinical data in acute ischemic stroke and the strategy of reperfusion therapy

  2020cites this paper
• Predictive value of inflammatory markers for functional outcomes in patients with ischemic stroke

  2020cites this paper
• Effect of uric acid in animal models of ischemic stroke: A systematic review and meta-analysis

  2020cites this paper
• CNS and peripheral immunity in cerebral ischemia: partition and interaction.

  2020cites this paper
• Взаимосвязь динамики сывороточных концентраций интерлейкина-1β, интерлейкина-6 и интерлейкина-10 с клиническими данными в остром периоде ишемического инсульта в зависимости от стратегии реперфузионной терапии

  2020cites this paper
• Is Animal-based Biomedical Research Being Used in Its Original Context?

  2019cites this paper
• Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019

  2019cites this paper
• Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review

  2019cites this paper
• Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential

  2019cites this paper
• Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis

  2019cites this paper
• Monoclonal Antibody as an Emerging Therapies for Ischemic Stroke

  2019cites this paper
• Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis

  2019cites this paper
• Anti-inflammatory treatments for stroke: from bench to bedside

  2018cites this paper
• Hyperacute changes in blood mRNA expression profiles of rats after middle cerebral artery occlusion: Towards a stroke time signature

  2018cites this paper
• Myeloid Cell and Transcriptome Signatures Associated With Inflammation Resolution in a Model of Self-Limiting Acute Brain Inflammation

  2018cites this paper
• Animal models of chemotherapy-induced peripheral neuropathy: a machine-assisted systematic review and meta-analysis

  2018cites this paper
• Clinical studies and anti‐inflammatory mechanisms of treatments

  2017cites this paper
• Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art

  2017cites this paper
• Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.

  2017cites this paper
• Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia

  2017cites this paper
• False positive results in preclinical research.

  2017cites this paper
• Analyses of the Dual Immune Roles Cytokines Play in Ischemic Stroke

  2017cites this paper
• Systematic Review and Meta-analysis: Important Tools in Understanding Drug Development for Stroke

  2017cites this paper
• Therapies negating neuroinflammation after brain trauma.

  2016cites this paper
• Interleukin-1 in Stroke: From Bench to Bedside.

  2016cites this paper
• Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model

  2016cites this paper
• Therapeutics targeting the inflammasome after central nervous system injury.

  2016cites this paper
• Explorer Systematic review and meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke : an update

  2016cites this paper
• Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist

  2016cites this paper
• Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

  2016cites this paper
• Clinical Trials of Immunomodulation in Ischemic Stroke

  2016cites this paper
• Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury

  2016cites this paper
• NLRP3 Is Involved in Ischemia/Reperfusion Injury.

  2016cites this paper
• Co-transplantation of Endothelial Progenitor Cells and Neural Progenitor Cells for Treating Ischemic Stroke in a Mouse Model

  2016cites this paper
• Myeloid cell involvement during the resolution of acute brain inflammation

  2016cites this paper
• Interleukin-1 and acute brain injury

  2015cites this paper
• Neuroprotection for ischaemic stroke: current status and challenges.

  2015cites this paper
• Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target.

  2015cites this paper
• The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs.

  2015cites this paper
• Relationships among APOE Genotypes, Inflammatory Markers, and Risk Factors among African Americans with Ischemic Stroke

  2015cites this paper
• Protective Role of Anakinra Against Transthyretin-Mediated Axonal Loss and Cell Death in a Mouse Model of Familial Amyloidotic Polyneuropathy

  2015cites this paper
• TSPO imaging in stroke: from animal models to human subjects

  2015cites this paper
• Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke

  2015cites this paper
• Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke

  2015cites this paper
• Cardiovascular pharmacotherapy: Innovation stuck in translation.

  2015cites this paper
• The role of the inflammasome in cardiovascular diseases

  2014cites this paper
• The Yin and Yang of Innate Immunity in Stroke

  2014cites this paper
• Inflammatory Mechanisms as Potential Therapeutic Targets in Stroke

  2014cites this paper
• Cerebral stroke injury: the role of cytokines and brain inflammation

  2014cites this paper
• The Need for Randomization in Animal Trials: An Overview of Systematic Reviews

  2014cites this paper
• Functional polymorphisms in toll-like receptor 4 are associated with worse outcome in acute ischemic stroke patients

  2014cites this paper
• Stroke, IL-1ra, IL1RN, Infection and Outcome

  2014cites this paper
• Critical appraisal of studies using laboratory animal models.

  2014cites this paper
• Pitfalls in microdialysis methodology: an in vitro analysis of temperature, pressure and catheter use

  2014cites this paper
• eview athogenesis of acute stroke and the role of inflammasomes avid

  2013cites this paper
• MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury.

  2013cites this paper
• A Systematic Review and Meta-Analysis of Buyang Huanwu Decoction in Animal Model of Focal Cerebral Ischemia

  2013cites this paper
• Inflammatory Consequences in a Rodent Model of Mild Traumatic Brain Injury

  2013cites this paper
• Pathophysiology of post-stroke hyperglycaemia and brain arterial patency

  2013cites this paper
• Pathogenesis of acute stroke and the role of inflammasomes.

  2013cites this paper
• Pivotal Roles of Monocytes/Macrophages in Stroke

  2013cites this paper
• Stress and social isolation increase vulnerability to stroke.

  2012cites this paper
• The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.

  2012cites this paper
• Vascular Targets for Ischemic Stroke Treatment

  2012cites this paper
• Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues.

  2012cites this paper
• Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.

  2012cites this paper
• Systematic Review and Meta-Analysis of the Efficacy of Statins in Experimental Stroke

  2012cites this paper
• Interleukin-1β Accelerates the Onset of Stroke in Stroke-Prone Spontaneously Hypertensive Rats

  2012cites this paper
• Neuroprotection for Stroke: Current Status and Future Perspectives

  2012cites this paper
• Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke.

  2012cites this paper
• Delayed Administration of Interleukin-1 Receptor Antagonist Reduces Ischemic Brain Damage and Inflammation in Comorbid Rats

  2012cites this paper
• Inflammatory Cytokines in Experimental and Human Stroke

  2012cites this paper
• Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration.

  2011cites this paper
• Hyperglycaemia and Infarct Size in Animal Models of Middle Cerebral Artery Occlusion: Systematic Review and Meta-Analysis

  2011cites this paper
• Stroke induced brain changes: Implications for stem cell transplantation.

  2011cites this paper
• Actions of interleukin-1 receptor antagonist in cerebral ischaemia

  2011cites this paper
• Stroke and the immune system: from pathophysiology to new therapeutic strategies.

  2011cites this paper
• Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target

  2011cites this paper
• Vascular Protection Following Cerebral Ischemia and Reperfusion.

  2011cites this paper
• Post-Stroke Infection: A Role for IL-1ra?

  2011cites this paper
• The inflammasomes in kidney disease.

  2011cites this paper
• Potential future neuroprotective therapies for neurodegenerative disorders and stroke.

  2010cites this paper